Study examines fingolimod therapy in patients with multiple sclerosis
The medication fingolimod reduced inflammatory lesion activity and reduced brain volume loss in patients with multiple sclerosis who participated in a two-year placebo-controlled clinical trial and were assessed by magnetic ...
Jul 2, 2012
0
0